| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/21/2007 | EP1529047B1 New purine derivatives |
| 02/21/2007 | EP1523325A4 Methods and compositions for treating polycystic ovary syndrome |
| 02/21/2007 | EP1519726B1 Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseases |
| 02/21/2007 | EP1511727B1 Aromatic sulfones and their medical use |
| 02/21/2007 | EP1501508B1 Inhibitors of histone deacetylase |
| 02/21/2007 | EP1463513B1 Stabilized brivudine topical formulations |
| 02/21/2007 | EP1458725B1 A novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent |
| 02/21/2007 | EP1458690B1 5,6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists |
| 02/21/2007 | EP1406857B1 Substituted 1-aryl-but-3-enylamine and 1-aryl-but-2-enylamine compounds |
| 02/21/2007 | EP1397126B9 Use of tramadol for delaying ejaculation |
| 02/21/2007 | EP1392281B1 Anti-endoparasitic amidoacetonitrils |
| 02/21/2007 | EP1389466B1 A dispersion on the basis of beta-glucan containing superfine particles, a corresponding process of manufacturing and the use of said dispersion |
| 02/21/2007 | EP1358156B1 Benz(g) indoles and their use as spla2 inhibitors |
| 02/21/2007 | EP1357901B1 Process for preparing particles |
| 02/21/2007 | EP1356811B1 Combination of three substances for the prevention or treatment of arthritis |
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/21/2007 | EP1339428B1 Inhalation of nitric oxide |
| 02/21/2007 | EP1328254B1 Lipid formulations for target delivery |
| 02/21/2007 | EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/21/2007 | EP1294422A4 Methods and systems for enhancing fluid flow through an obstructed vascular site |
| 02/21/2007 | EP1292332B1 ADJUVANTS AND PROCESSES TO INDUCE A Th2 IMMUNE RESPONSE |
| 02/21/2007 | EP1290006B1 Combinatorial production of nucleotide and nucleoside (XITP) analogues |
| 02/21/2007 | EP1276459B8 Cosmetic or dermatological cream composition, the preparation and the use thereof |
| 02/21/2007 | EP1255749B1 Tyrosine derivatives with anti-leukotriene activity |
| 02/21/2007 | EP1251847B1 Novel use of prodigiosin for treating diabetes mellitus |
| 02/21/2007 | EP1248605B1 Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them |
| 02/21/2007 | EP1232177B1 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 02/21/2007 | EP1230922B9 Agents for promoting fattening of animals and method of promoting fattening |
| 02/21/2007 | EP1224155B1 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 02/21/2007 | EP1189602B1 Morphine sulphate microgranules, method for preparing same and compositions containing same |
| 02/21/2007 | EP1165570B9 Novel phosphorus-containing prodrugs |
| 02/21/2007 | EP1140962B1 Novel derivatives from the class of oleandomycin |
| 02/21/2007 | EP1140071B1 Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors |
| 02/21/2007 | EP1139980B1 Cosmetic or medical preparation for topical use |
| 02/21/2007 | EP1135503B1 Drug targets in candida albicans |
| 02/21/2007 | EP1135374B9 Benzimidazole compounds that are vitronectin receptor antagonists |
| 02/21/2007 | EP1133474B1 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators |
| 02/21/2007 | EP1086225B1 Human tumour-derived polypeptide hormone phosphatonin |
| 02/21/2007 | EP1057483B1 Composition comprising theanine |
| 02/21/2007 | EP0954334B1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy |
| 02/21/2007 | EP0894004B2 Method for enhancing functional recovery of motor coordination, speech or sensory perception after central nervous system ischemia or trauma |
| 02/21/2007 | EP0871485B1 COMPOSITIONS AND METHODS FOR CATALYZING HYDROLYSIS OF HIV gp120 |
| 02/21/2007 | EP0797456B1 Anticancer drug with a cytostatic and a contrasting agent |
| 02/21/2007 | CN1918512A Still camera with audio decoding and coding, a printable audio format, and method |
| 02/21/2007 | CN1918293A Substituted non-coding nucleic acid molecule for therapeutic or prophylaxis immunological stimulus for human and higher animal |
| 02/21/2007 | CN1918292A Oligomeric compounds for the modulation of bcl-2 |
| 02/21/2007 | CN1918242A Compositions containing cis-isomers of carotenoids and corresponding method |
| 02/21/2007 | CN1918175A Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 02/21/2007 | CN1918172A 利福霉素类似物及其用途 Rifamycin analogs and their use |
| 02/21/2007 | CN1918171A Chemokine ccr5 receptor modulators |
| 02/21/2007 | CN1918170A 7-polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groups |
| 02/21/2007 | CN1918169A Cysteine protease inhibitors |
| 02/21/2007 | CN1918167A Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
| 02/21/2007 | CN1918166A 烟碱乙酰胆碱受体配体 Nicotinic acetylcholine receptor ligands |
| 02/21/2007 | CN1918165A Azabicyclic heterocycles as cannabinoid receptor modulators |
| 02/21/2007 | CN1918164A Azabicyclic heterocycles as cannabinoid receptor modulators |
| 02/21/2007 | CN1918163A Fused pyrrolocarbazoles and methods for the preparation thereof |
| 02/21/2007 | CN1918162A Novel fused pyrrolocarbazoles |
| 02/21/2007 | CN1918161A Tricyclic imidazopyridines and intermediates for the synthesis thereof |
| 02/21/2007 | CN1918160A Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 02/21/2007 | CN1918159A Prodrugs of substituted amino heterobicycles which modulate the function of the vanilloid-1 receptor (vr1) |
| 02/21/2007 | CN1918158A Compounds and compositions as protein kinase inhibitors |
| 02/21/2007 | CN1918157A Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
| 02/21/2007 | CN1918156A Isothiazole dioxides as cxc- and cc-chemokine receptor ligands |
| 02/21/2007 | CN1918154A Poly-heterocyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 02/21/2007 | CN1918153A Oxazole derivatives, preparation and therapeutic use thereof |
| 02/21/2007 | CN1918152A C10 cyclopentyl ester substituted taxanes |
| 02/21/2007 | CN1918151A Tricyclic steroid hormone nuclear receptor modulators |
| 02/21/2007 | CN1918148A Substituted benzimidazoles and their use for inducing apoptosis |
| 02/21/2007 | CN1918147A 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof |
| 02/21/2007 | CN1918146A Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 02/21/2007 | CN1918145A Amino heterocyclic modulators of chemokine receptor activity |
| 02/21/2007 | CN1918144A Anthranilamide-based compound, method for producing the same, and pest-controlling agent containing the same |
| 02/21/2007 | CN1918139A Cinnamic amides, process for their preparation, and pharmaceutical compositions containing them |
| 02/21/2007 | CN1918138A Thiadiazoles as cxc- and cc- chemokine receptor ligands |
| 02/21/2007 | CN1918137A Tetrazole compounds and their use as metabotropic glutamate receptor antagonists |
| 02/21/2007 | CN1918134A Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cyto kine inhibitors |
| 02/21/2007 | CN1918133A Alpha-4 integrin mediated cell adhesion inhibitors for the treatment or prevention of inflammatory diseases |
| 02/21/2007 | CN1918131A Novel inhibitors of glutaminyl cyclase |
| 02/21/2007 | CN1918129A Therapeutic agent |
| 02/21/2007 | CN1918128A Fused ring 4-oxopyrimidine derivative |
| 02/21/2007 | CN1918127A New cyclocompound having 4-pyridylalkylthio group to which sustituted or unsubstituted amino group is introduced |
| 02/21/2007 | CN1918126A Ionic uv-a sunscreens and compositions containing them |
| 02/21/2007 | CN1918124A New pyridin-2-one compounds useful as inhibitors of thrombin |
| 02/21/2007 | CN1918123A Extractive of marasmius androsaceus, derivative of piperidone, and appliction for preparing medication of anti high blood pressure |
| 02/21/2007 | CN1918122A Novel benzofurans and indols |
| 02/21/2007 | CN1918121A Pyrrole-3-carboxamide derivatives for the treatment of obesity |
| 02/21/2007 | CN1918119A Bicycloester derivative |
| 02/21/2007 | CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 02/21/2007 | CN1918114A Substituted n-aryl amidines as selective d1 dopamine receptor antagonists for the treatment of obesity and cns disorders |
| 02/21/2007 | CN1918113A Androgen receptor modulators |
| 02/21/2007 | CN1918111A Formulation auxiliary agents |
| 02/21/2007 | CN1917922A Use of substituted 1,2,3 indolizine derivatives in the preparation of medicaments which can be used to treat diseases linked to pathological choroidal angiogenesis |
| 02/21/2007 | CN1917921A Calcitonin gene related peptide receptor antagonists |
| 02/21/2007 | CN1917904A Use of organo-silicon compounds for constraining connective damaged tissues |
| 02/21/2007 | CN1917903A New combinations of an anti emetic agent and an enkephalinase inhibitor |
| 02/21/2007 | CN1917894A Muscular tension-elevating agent |
| 02/21/2007 | CN1917890A Composition and method for use in cartilage affecting conditions |
| 02/21/2007 | CN1917889A Use of gallium to treat inflammatory arthritis |
| 02/21/2007 | CN1917888A Solid formulation for dialysis and process for producing the same |